Heejong Sung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Heejong Sung has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Arbona-Lampaya
School of Medicine, University of Puerto Rico, San Juan, Puerto Rico
2 shared publications Alexander D'Amico
National Institute of Mental Health
2 shared publications- Alexander F. Wilson
Computational and Statistical Genomics Branch National Human Genome Research Institute, National Institutes of Health Bethesda MD USA
2 shared publications - Alexander Pemov
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America
2 shared publications Ally Freifeld
National Institute of Mental Health
2 shared publicationsAndrea M. Baldwin
2 shared publications
Latest Publications
- Open Access
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S307-S308
528. Heritability of Mood Disorder Questionnaire Scores in Families Affected by Bipolar Disorder
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S307-S308
Open Access528. Heritability of Mood Disorder Questionnaire Scores in Families Affected by Bipolar Disorder
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S261
413. Heritability of Cognitive Functioning in Patients With Bipolar Disorder and Their Unaffected Relatives
- 10 April 2023
- Published by Elsevier in Biological Psychiatry
- Vol. 93 (9) , S261
413. Heritability of Cognitive Functioning in Patients With Bipolar Disorder and Their Unaffected Relatives
- Open Access
- 12 October 2020
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (10)
Cover
- 12 October 2020
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (10)
Open AccessCover
- Open Access
- 31 August 2020
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (10)
Genome‐wide association study of café‐au‐lait macule number in neurofibromatosis type 1
Background: Neurofibromatosis type 1 (NF1) is a tumor‐predisposition disorder that arises due to pathogenic variants in tumor suppressor NF1. NF1 has variable expressivity that may be due, at least in part, from heritable elements such as modifier genes; however, few genetic modifiers have been identified to date.Methods: In this study, we performed a genome‐wide association analysis of the number of café‐au‐lait macules (CALM) that are considered a tumor‐like trait as a clinical phenotype modifying NF1.Results: A borderline genome‐wide significant association was identified in the discovery cohort (CALM1, N = 112) between CALM number and rs12190451 (and rs3799603, r2 = 1.0; p = 7.4 × 10−8) in the intronic region of RPS6KA2. Although, this association was not replicated in the second cohort (CALM2, N = 59) and a meta‐analysis did not show significantly associated variants in this region, a significant corroboration score (0.72) was obtained for the RPS6KA2 signal in the discovery cohort (CALM1) using Complementary Pairs Stability Selection for Genome‐Wide Association Studies (ComPaSS‐GWAS) analysis, suggesting that the lack of replication may be due to heterogeneity of the cohorts rather than type I error.Conclusion: rs12190451 is located in a melanocyte‐specific enhancer and may influence RPS6KA2 expression in melanocytes—warranting further functional studies.
- 31 August 2020
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (10)
Open AccessGenome‐wide association study of café‐au‐lait macule number in neurofibromatosis type 1
Background: Neurofibromatosis type 1 (NF1) is a tumor‐predisposition disorder that arises due to pathogenic variants in tumor suppressor NF1. NF1 has variable expressivity that may be due, at least in part, from heritable elements such as modifier genes; however, few genetic modifiers have been identified to date.Methods: In this study, we performed a genome‐wide association analysis of the number of café‐au‐lait macules (CALM) that are considered a tumor‐like trait as a clinical phenotype modifying NF1.Results: A borderline genome‐wide significant association was identified in the discovery cohort (CALM1, N = 112) between CALM number and rs12190451 (and rs3799603, r2 = 1.0; p = 7.4 × 10−8) in the intronic region of RPS6KA2. Although, this association was not replicated in the second cohort (CALM2, N = 59) and a meta‐analysis did not show significantly associated variants in this region, a significant corroboration score (0.72) was obtained for the RPS6KA2 signal in the discovery cohort (CALM1) using Complementary Pairs Stability Selection for Genome‐Wide Association Studies (ComPaSS‐GWAS) analysis, suggesting that the lack of replication may be due to heterogeneity of the cohorts rather than type I error.Conclusion: rs12190451 is located in a melanocyte‐specific enhancer and may influence RPS6KA2 expression in melanocytes—warranting further functional studies.
- 18 October 2018
- Published by Wiley in Genetic Epidemiology
- Vol. 43 (1) , 102-111
ComPaSS‐GWAS: A method to reduce type I error in genome‐wide association studies when replication data are not available
Results from association studies are traditionally corroborated by replicating the findings in an independent data set. Although replication studies may be comparable for the main trait or phenotype of interest, it is unlikely that secondary phenotypes will be comparable across studies, making replication problematic. Alternatively, there may simply not be a replication sample available because of the nature or frequency of the phenotype. In these situations, an approach based on complementary pairs stability selection for genome‐wide association study (ComPaSS‐GWAS), is proposed as an ad‐hoc alternative to replication. In this method, the sample is randomly split into two conditionally independent halves multiple times (resamples) and a GWAS is performed on each half in each resample. Similar in spirit to testing for association with independent discovery and replication samples, a marker is corroborated if its p‐value is significant in both halves of the resample. Simulation experiments were performed for both nongenetic and genetic models. The type I error rate and power of ComPaSS‐GWAS were determined and compared to the statistical properties of a traditional GWAS. Simulation results show that the type I error rate decreased as the number of resamples increased with only a small reduction in power and that these results were comparable with those from a traditional GWAS. Blood levels of vitamin pyridoxal 5′‐phosphate from the Trinity Student Study (TSS) were used to validate this approach. The results from the validation study were compared to, and were consistent with, those obtained from previously published independent replication data and functional studies.
- 18 October 2018
- Published by Wiley in Genetic Epidemiology
- Vol. 43 (1) , 102-111
ComPaSS‐GWAS: A method to reduce type I error in genome‐wide association studies when replication data are not available
Results from association studies are traditionally corroborated by replicating the findings in an independent data set. Although replication studies may be comparable for the main trait or phenotype of interest, it is unlikely that secondary phenotypes will be comparable across studies, making replication problematic. Alternatively, there may simply not be a replication sample available because of the nature or frequency of the phenotype. In these situations, an approach based on complementary pairs stability selection for genome‐wide association study (ComPaSS‐GWAS), is proposed as an ad‐hoc alternative to replication. In this method, the sample is randomly split into two conditionally independent halves multiple times (resamples) and a GWAS is performed on each half in each resample. Similar in spirit to testing for association with independent discovery and replication samples, a marker is corroborated if its p‐value is significant in both halves of the resample. Simulation experiments were performed for both nongenetic and genetic models. The type I error rate and power of ComPaSS‐GWAS were determined and compared to the statistical properties of a traditional GWAS. Simulation results show that the type I error rate decreased as the number of resamples increased with only a small reduction in power and that these results were comparable with those from a traditional GWAS. Blood levels of vitamin pyridoxal 5′‐phosphate from the Trinity Student Study (TSS) were used to validate this approach. The results from the validation study were compared to, and were consistent with, those obtained from previously published independent replication data and functional studies.
- Open Access
- 15 December 2009
- Published by Springer Nature in BMC Proceedings
- Vol. 3 (S7) , S64
Evaluation of random forests performance for genome-wide association studies in the presence of interaction effects
Random forests (RF) is one of a broad class of machine learning methods that are able to deal with large-scale data without model specification, which makes it an attractive method for genome-wide association studies (GWAS). The performance of RF and other association methods in the presence of interactions was evaluated using the simulated data from Genetic Analysis Workshop 16 Problem 3, with knowledge of the major causative markers, risk factors, and their interactions in the simulated traits. There was good power to detect the environmental risk factors using RF, trend tests, or regression analyses but the power to detect the effects of the causal markers was poor for all methods. The causal marker that had an interactive effect with smoking did show moderate evidence of association in the RF and regression analyses, suggesting that RF may perform well at detecting such interactions in larger, more highly powered datasets.
- 15 December 2009
- Published by Springer Nature in BMC Proceedings
- Vol. 3 (S7) , S64
Open AccessEvaluation of random forests performance for genome-wide association studies in the presence of interaction effects
Random forests (RF) is one of a broad class of machine learning methods that are able to deal with large-scale data without model specification, which makes it an attractive method for genome-wide association studies (GWAS). The performance of RF and other association methods in the presence of interactions was evaluated using the simulated data from Genetic Analysis Workshop 16 Problem 3, with knowledge of the major causative markers, risk factors, and their interactions in the simulated traits. There was good power to detect the environmental risk factors using RF, trend tests, or regression analyses but the power to detect the effects of the causal markers was poor for all methods. The causal marker that had an interactive effect with smoking did show moderate evidence of association in the RF and regression analyses, suggesting that RF may perform well at detecting such interactions in larger, more highly powered datasets.